Christopher Cabell - 21 Feb 2026 Form 4 Insider Report for Inhibikase Therapeutics, Inc. (IKT)

Role: President & Head of R&D
Signature: /s/ Mark Iwicki, attorney-in-fact
Issuer symbol: IKT
Transactions as of: 21 Feb 2026
Net transactions value: $0
Form type: 4
Filing time: 24 Feb 2026, 20:53:37 UTC
Previous filing: 07 Jan 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Cabell Christopher	President & Head of R&D	1000 N. WEST STREET, SUITE 1200, WILMINGTON	/s/ Mark Iwicki, attorney-in-fact	24 Feb 2026	0001814928

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IKT	Common Stock	Disposed to Issuer	$0	-338,282	-33%	$0.000000	676,564	21 Feb 2026	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	As previously reported on a Form 3/A filed on August 28, 2025, the Reporting Person received shares of Issuer common stock as merger consideration upon the completion of the acquisition of CorHepta Pharmaceuticals, Inc. on February 21, 2025 (the "Closing Date"), with 338,282 shares subject to forfeiture if a certain milestone is not achieved by the first anniversary of the Closing Date. On February 21, 2026, it was determined that such milestone was not achieved, resulting in the forfeiture of all 338,282 shares. The Reporting Person received no consideration from the Issuer in connection with such forfeiture.

Content

As previously reported on a Form 3/A filed on August 28, 2025, the Reporting Person received shares of Issuer common stock as merger consideration upon the completion of the acquisition of CorHepta Pharmaceuticals, Inc. on February 21, 2025 (the "Closing Date"), with 338,282 shares subject to forfeiture if a certain milestone is not achieved by the first anniversary of the Closing Date. On February 21, 2026, it was determined that such milestone was not achieved, resulting in the forfeiture of all 338,282 shares. The Reporting Person received no consideration from the Issuer in connection with such forfeiture.